Cargando…

Hypoxia activates Wnt/β-catenin signaling by regulating the expression of BCL9 in human hepatocellular carcinoma

The Wnt/β-catenin signaling is abnormally activated in the progression of hepatocellular carcinoma (HCC). BCL9 is an essential co-activator in the Wnt/β-catenin signaling. Importantly, BCL9 is absent from tumors originating from normal cellular counterparts and overexpressed in many cancers includin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Wei, Zhou, Wang, Cheng, Mo, Wang, Jing, Liu, Zhian, He, Shaohui, Luo, Xiangji, Huang, Wending, Chen, Tianrui, Yan, Wangjun, Xiao, Jianru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225427/ https://www.ncbi.nlm.nih.gov/pubmed/28074862 http://dx.doi.org/10.1038/srep40446

Ejemplares similares

The function of BCL9 in Wnt/β-catenin signaling and colorectal cancer cells
por: de la Roche, Marc, et al.
Publicado: (2008)

Tuning WNT-β-catenin signaling via BCL9 proteins for targeting colorectal cancer cells
por: Beaulieu, Jean-François
Publicado: (2015)

miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt/β-catenin signaling through targeting BCL9
por: Yang, Chao, et al.
Publicado: (2017)

Matrix stiffness promotes glioma cell stemness by activating BCL9L/Wnt/β-catenin signaling
por: Tao, Bei, et al.
Publicado: (2021)

BCL9/BCL9L in hepatocellular carcinoma: Will it or Wnt it be the next therapeutic target?
por: Moghe, Akshata, et al.
Publicado: (2020)

Retraction Note: miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt/β-catenin signaling through targeting BCL9
por: Yang, Chao, et al.
Publicado: (2023)

Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma
por: Huge, Nicole, et al.
Publicado: (2019)

Aristaless Related Homeobox (ARX) Interacts with β-Catenin, BCL9, and P300 to Regulate Canonical Wnt Signaling
por: Cho, Il-Taeg, et al.
Publicado: (2017)

Wnt/β-Catenin Signalling and Its Cofactor BCL9L Have an Oncogenic Effect in Bladder Cancer Cells
por: Kotolloshi, Roland, et al.
Publicado: (2022)

Let-7b contributes to hepatocellular cancer progression through Wnt/β-catenin signaling
por: Wang, Yiwei, et al.
Publicado: (2018)

The Wnt/β-catenin signaling pathway in the tumor microenvironment of hepatocellular carcinoma
por: Wang, Kaiting, et al.
Publicado: (2022)

Bcl-3 promotes Wnt signaling by maintaining the acetylation of β-catenin at lysine 49 in colorectal cancer
por: Chen, Xi, et al.
Publicado: (2020)

Mutations in Bcl9 and Pygo genes cause congenital heart defects by tissue-specific perturbation of Wnt/β-catenin signaling
por: Cantù, Claudio, et al.
Publicado: (2018)

Wnt/β-Catenin Signaling and Obesity
por: Chen, Na, et al.
Publicado: (2018)

A novel β-catenin/BCL9 complex inhibitor blocks oncogenic Wnt signaling and disrupts cholesterol homeostasis in colorectal cancer
por: Tanton, Helen, et al.
Publicado: (2022)

Inhibition of wnt/β-catenin Signaling in Hepatocellular Carcinoma by an Antipsychotic Drug Pimozide
por: Fako, Valerie, et al.
Publicado: (2016)

BCL9, a coactivator for Wnt/β-catenin transcription, is targeted by miR-30c and is associated with prostate cancer progression
por: LING, XIAO-HUI, et al.
Publicado: (2016)

Hypoxia-inducible factor 1α induces osteo/odontoblast differentiation of human dental pulp stem cells via Wnt/β-catenin transcriptional cofactor BCL9
por: Orikasa, Shion, et al.
Publicado: (2022)

KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer
por: Yao, Hanhui, et al.
Publicado: (2022)

BCL9/9L-β-catenin Signaling is Associated With Poor Outcome in Colorectal Cancer
por: Moor, Andreas E., et al.
Publicado: (2015)

GSTZ1‐1 downregulates Wnt/β‐catenin signalling in hepatocellular carcinoma cells
por: Lei, Chong, et al.
Publicado: (2019)

The interactions of Bcl9/Bcl9L with β-catenin and Pygopus promote breast cancer growth, invasion, and metastasis
por: Vafaizadeh, Vida, et al.
Publicado: (2021)

Role of Wnt/β-catenin signaling in hepatocellular carcinoma, pathogenesis, and clinical significance
por: Khalaf, Ahmed M, et al.
Publicado: (2018)

Clinical Significance of the Duality of Wnt/β-Catenin Signaling in Human Hepatocellular Carcinoma
por: Aoki, Tomoko, et al.
Publicado: (2022)

Wnt/β-Catenin Signaling in Liver Cancers
por: Wang, Wenhui, et al.
Publicado: (2019)

BCL11A enhances stemness and promotes progression by activating Wnt/β-catenin signaling in breast cancer
por: Zhu, Lewei, et al.
Publicado: (2019)

Aquaporin 9 inhibits growth and metastasis of hepatocellular carcinoma cells via Wnt/β-catenin pathway
por: Liao, Shengtao, et al.
Publicado: (2020)

WNKs in Wnt/β-catenin signaling
por: Serysheva, Ekatherina, et al.
Publicado: (2014)

Sox9 confers stemness properties in hepatocellular carcinoma through Frizzled-7 mediated Wnt/β-catenin signaling
por: Leung, Carmen Oi-Ning, et al.
Publicado: (2016)

Hypoxia-regulated human periodontal ligament cells via Wnt/β-catenin signaling pathway
por: Xiao, Zhili, et al.
Publicado: (2017)

Protective effect of autophagy in neural ischemia and hypoxia: Negative regulation of the Wnt/β-catenin pathway
por: Shi, Zhen-Yu, et al.
Publicado: (2017)

Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells
por: Ma, Li, et al.
Publicado: (2015)

Kindlin-2 promotes hepatocellular carcinoma invasion and metastasis by increasing Wnt/β-catenin signaling
por: Lin, Jie, et al.
Publicado: (2017)

PORCN promotes hepatocellular carcinogenesis via Wnt/β-catenin-dependent manner
por: Wu, Shuzhen, et al.
Publicado: (2023)

Stratifin Promotes Hepatocellular Carcinoma Progression by Modulating the Wnt/β-Catenin Pathway
por: Ye, Shan-Ping, et al.
Publicado: (2023)

Targeting the Wnt/β-catenin signaling pathway in cancer
por: Zhang, Ya, et al.
Publicado: (2020)

Dysregulation of Wnt/β‐catenin signaling by protein kinases in hepatocellular carcinoma and its therapeutic application
por: Li, Qian, et al.
Publicado: (2021)

Apigenin-induced lysosomal degradation of β-catenin in Wnt/β-catenin signaling
por: Lin, Chung-Ming, et al.
Publicado: (2017)

Wnt/β-Catenin Signaling as a Driver of Stemness and Metabolic Reprogramming in Hepatocellular Carcinoma
por: Leung, Rainbow Wing Hei, et al.
Publicado: (2022)

Wnt/β-catenin signaling in cancers and targeted therapies
por: Yu, Fanyuan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6knf79pl500ssb085oqdfdgap9